Previous 10 | Next 10 |
Innovative approaches in MRI technology demonstrate the potential of portable ultra-low-field MR brain imaging to aid physicians in the diagnosis of acute ischemic stroke Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging wi...
The latest software, the eighth generation of Swoop® system software, has obtained CE and UKCA approval Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking medical device company that has redefined brain imaging with the world’s first FDA-cleared portable magnetic resonance b...
2023-11-30 16:27:00 ET More on Hyperfine Hyperfine, Inc. (HYPR) Q3 2023 Earnings Call Transcript Hyperfine, Inc. 2023 Q3 - Results - Earnings Call Presentation Hyperfine: Swoop-Ing In On The Low-Field MRI Opportunity Hyperfine shares up after receiving FDA cl...
Innovative approaches in MRI technology demonstrate the potential of portable ultra-low-field brain imaging to assist in improving brain health Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking medical device company that has redefined brain imaging with the world’s first FDA-cl...
Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking medical device company that has redefined brain imaging with the world’s first FDA-cleared, portable, ultra-low-field, magnetic resonance brain imaging system—the Swoop® system—today announced plans to present at the upc...
2023-11-10 18:31:02 ET Hyperfine, Inc. (HYPR) Q3 2023 Earnings Call November 9, 2023 04:30 PM ET Company Participants Marissa Bych - Investor Relations Maria Sainz - President and Chief Executive Officer Brett Hale - Chief Administrative Officer and Chief Financi...
2023-11-09 16:59:16 ET More on Hyperfine Hyperfine: Swoop-Ing In On The Low-Field MRI Opportunity Hyperfine shares up after receiving FDA clearance for updated AI-powered software Seeking Alpha’s Quant Rating on Hyperfine For further details see: H...
2023-11-09 16:32:20 ET More on Hyperfine Hyperfine: Swoop-Ing In On The Low-Field MRI Opportunity Hyperfine's Portable MRI Scanner Will Likely Be A Winner Hyperfine Inc. (HYPR) Q2 2023 Earnings Call Transcript Hyperfine shares up after receiving FDA clearance...
GUILFORD, Conn., Nov. 09, 2023 (GLOBE NEWSWIRE) -- Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking medical device company that has redefined brain imaging with the world’s first FDA-cleared, portable, ultra-low-field, magnetic resonance brain imaging system—the Swoop® system...
Histogen Inc. (HSTO) is expected to report for Q3 2023 News Corporation (NWSA) is expected to report $0.13 for Q1 2024 TORM plc (TRMD) is expected to report for Q3 2023 Blink Charging Co. (BLNK) is expected to report $-0.47 for Q3 2023 Nuvalent Inc. (NUVL) is expected to report $-...
News, Short Squeeze, Breakout and More Instantly...
The total number of Hyperfine AI-powered marketing authorizations places the company in a leading position on recently published FDA list. Hyperfine (Nasdaq: HYPR), the groundbreaking medical device company that has redefined brain imaging with the world’s first FDA-cleared porta...
The publication includes a subset of data from the ACTION PMR stroke study and provides early evidence that the Swoop ® system is a promising tool for enabling critical stroke treatment choices in urgent care settings. Hyperfine (Nasdaq: HYPR), the groundbreaking health technol...
Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared portable magnetic resonance (MR) brain imaging system—the Swoop® system—today announced that it will report financial results for the second ...